Telix Pharmaceuticals | TLX - Fremdkapital

Aktienkurs
12.50
Täglich Wechseln
-0.30 -2.34%
Monatlich
35.87%
Jährlich
-56.79%
Q1 Prognose
12.48




Fremdkapital Veränderung Datum
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Mayne Pharma AUD 2.66M 153K 2025-06
Medical Developments International AUD 1.5M 167K 2025-12
Mesoblast USD 66.02M 1.72M 2025-12
Pacific Edge NZD 551K 637K 2025-12
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
Polynovo AUD 15.39M 663K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sonic Healthcare AUD 4.19B 333.39M 2024-12